A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- NA
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of ABT-700 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Status
- COMPLETED
- Phase
- PHASE2
Pazopanib, Docetaxel, Prednisone Prostate
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder
- Status
- TERMINATED
- Phase
- PHASE2
Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3